home All News open_in_new Full Article

Arbutus Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Q2 total revenue of $10.7M includes previously-deferred revenue following reacquisition of Greater China rights to imdusiran Dr. Roger Sawhney joins the Arbutus Board of Directors following resignation of Anuj Hasija Dr. Harry Janssen joins the Arbutus Scientific Advisory Board Strong financial position with cash, cash equivalents and marketable securities of $98.1M WARMINSTER, Pa., Aug. 06, […]


today 8 d. ago attach_file Culture

attach_file Other
attach_file Other
attach_file Economics
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Other
attach_file Society
attach_file Other


ID: 2085307088
Add Watch Country

arrow_drop_down